sponsored
PatientsVille.com Logo

PatientsVille

Norfloxacin Medical Research Studies

Up-to-date List of Norfloxacin Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Norfloxacin Medical Research Studies

Rank Status Study
1 Recruiting Norfloxacin Versus Ciprofloxacin for Spontaneous Bacterial Peritonitis (SBP) Prevention
Condition: Adverse Reaction to Other Drugs and Medicines
Interventions: Drug: Norfloxacin;   Drug: ciprofloxacin
Outcome Measures: The prevention rate of spontaneous bacterial peritonitis (SBP);   1 year mortality;   Incidence of infectious event other than SBP;   Hepatorenal syndrome;   Hepatic encephalopathy;   Adverse event of drugs
2 Recruiting Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
Conditions: Spontaneous Bacterial Peritonitis;   Ascites;   Liver Cirrhosis
Interventions: Drug: Rifaximin;   Drug: Norfloxacin
Outcome Measure: Number of participants with recurrence of SBP
3 Unknown  Comparison in the Treatment of Acute Cystitis Using Cephalosporin and Norfloxacin (CECI)
Condition: Cystitis
Interventions: Drug: Norfloxacin;   Drug: Cephalosporins
Outcome Measures: Bacteriological Eradication;   Clinical Cure
4 Unknown  Probiotics for Portal Hypertension
Conditions: Cirrhosis;   Varices, Esophageal
Intervention: Drug: Propranolol, Norfloxacin, VSL#3
Outcome Measures: Change in HVPG levels as compared with baseline, to define responder (≥20% reduction in HVPG or ≤ 12 mm Hg).;   Assessment of improvement in the renal parameters and Systemic inflammatory response syndrome;   Adverse effects
5 Unknown  Role of Probiotics in the Prevention of Spontaneous Bacterial Peritonitis in Cirrhotic Patients: A Randomized Placebo Control Trial
Conditions: Spontaneous Bacterial Peritonitis;   Liver Cirrhosis
Interventions: Drug: Probiotics and Placebo;   Drug: Probiotics and Norfloxacin
Outcome Measures: Development of an episode of SBP, completion of one year, or death;   development of encephalopathy, variceal bleeding and renal failure
6 Recruiting Symptomatic Therapy of Uncomplicated Lower Urinary Tract Infections in the Ambulatory Setting.
Condition: Urinary Tract Infections
Interventions: Drug: Diclofenac;   Drug: Norfloxacin
Outcome Measures: The proportion of patients with resolution of symptoms on day 4;   The proportion of patients ever on antibiotics between randomization and day 30 of follow-up;   The proportion of patients using single dose fosfomycin on day 4;   The proportion of patients with re-consultations because of UTI within 30 days;   The mean composite symptom scores on days 4, 7 and 30;   The proportion of patients with resolution of symptoms on day 7;   The proportion of patients with complete resolution of symptoms on days 4 and 7;   The time until resolution of symptoms;   The proportion of patients with adverse events;   Mean overall patient stratification;   Health-related quality of life on day 4;   Number of working days lost
7 Not yet recruiting Patients Response to Early Switch To Oral:Osteomyelitis Study
Condition: Osteomyelitis
Interventions: Drug: oral antibiotics;   Procedure: intravenous antibiotics
Outcome Measures: Clinical Failures;   Evaluation of adverse events related to the use of antibiotics;   Cost of care from the hospital perspective
8 Unknown  Vasoactive Peptides in Portal Pressure
Condition: Portal Hypertension
Intervention: Drug: Norfloxacin
Outcome Measure:

These studies may lead to new treatments and are adding insight into Norfloxacin etiology and treatment.

A major focus of Norfloxacin research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.


Discuss Norfloxacin